Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
AstraZeneca
Age
40–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
≥ 1 prescription(s) fill for BGF on or following January 1, 2021
Patients must have evidence of a severe qualifying exacerbation event.
* The qualifying severe exacerbation event discharge date must occur within the 180-day period preceding the initiation of BGF for classification of patients into prompt or delayed initiators of BGF.
* The discharge date of the first (earliest) observed qualifying index exacerbation event will be set as the index date
≥ 12 months of continuous health plan enrollment preceding the qualifying index exacerbation event date (baseline period)
≥ 1 day of continuous enrollment following the qualifying index exacerbation date
Age ≥ 40 years on the qualifying index exacerbation date
You may not be if
Presence of cancer diagnoses other than basal or squamous cell skin cancer during the baseline period preceding the index date or entire follow-up period
Presence of ≥2 claims with a diagnosis of interstitial fibrosis or sarcoidosis diagnoses during the period preceding the index date or entire follow-up period
Presence of SITT at any time during the entire available history of patients' data preceding the index date through BGF initiation
Clareo Health | Exacerbations and Real-World Outcomes Among Patients With Chronic Obstructive Pulmonary Disease Following Severe Exacerbation
